Krystal Biotech buy Citigroup Inc.
Start price
12.10.23
/
50%
€106.00
Target price
12.10.24
-
Performance (%)
36.93%
Price
25.04.24
€145.15
Summary
This prediction is currently active. With a performance of 36.93% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 12.10.24. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Krystal Biotech | -2.420% | -2.420% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€179.60
27.02.25
27.02.25
-4.51%
25.04.24
25.04.24